Clinical Trial Update: Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating cisplatin, capecitabine, and radiation therapy with or without cetuximab in esophageal cancer (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Cetuximab (cetuximab)

Snippet

Sponsor: Wales Cancer Trials Unit | Conditions: Esophageal Cancer | Phase 2, Phase 3 | Status: UNKNOWN